MOMP, cell suicide as a BCL-2 family business H Kalkavan, DR Green Cell Death & Differentiation 25 (1), 46-55, 2018 | 708 | 2018 |
LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance LD Cunha, M Yang, R Carter, C Guy, L Harris, JC Crawford, G Quarato, ... Cell 175 (2), 429-441. e16, 2018 | 317 | 2018 |
Sublethal cytochrome c release generates drug-tolerant persister cells H Kalkavan, MJ Chen, JC Crawford, G Quarato, P Fitzgerald, SWG Tait, ... Cell 185 (18), 3356-3374. e22, 2022 | 133 | 2022 |
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy L Such, F Zhao, D Liu, B Thier, VTK Le-Trilling, A Sucker, C Coch, ... The Journal of clinical investigation 130 (8), 4266-4281, 2020 | 59 | 2020 |
Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity C Göbel, F Breitenbuecher, H Kalkavan, PS Hähnel, S Kasper, S Hoffarth, ... Cell death & disease 5 (12), e1568-e1568, 2014 | 52 | 2014 |
Regulation of apoptosis by an intrinsically disordered region of Bcl-xL AV Follis, F Llambi, H Kalkavan, Y Yao, AH Phillips, CG Park, FM Marassi, ... Nature chemical biology 14 (5), 458-465, 2018 | 51 | 2018 |
Cancer metastasis: molecular mechanisms and clinical perspectives SU Khan, K Fatima, F Malik, H Kalkavan, A Wani Pharmacology & Therapeutics, 108522, 2023 | 50 | 2023 |
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma K Herbert, R Binet, JP Lambert, P Louphrasitthiphol, H Kalkavan, ... Genes & development 33 (5-6), 310-332, 2019 | 45 | 2019 |
Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis DA Rodriguez, G Quarato, S Liedmann, B Tummers, T Zhang, C Guy, ... Proceedings of the National Academy of Sciences 119 (41), e2207240119, 2022 | 35 | 2022 |
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression H Kalkavan, P Sharma, S Kasper, I Helfrich, AA Pandyra, A Gassa, ... Nature Communications 8 (1), 14447, 2017 | 32 | 2017 |
Non-lethal outcomes of engaging regulated cell death pathways in cancer H Kalkavan, S Rühl, JJP Shaw, DR Green Nature cancer 4 (6), 795-806, 2023 | 24 | 2023 |
IL-10 induces T cell exhaustion during transplantation of virus infected hearts A Gassa, F Jian, H Kalkavan, V Duhan, N Honke, N Shaabani, ... Cellular Physiology and Biochemistry 38 (3), 1171-1181, 2016 | 14 | 2016 |
High frequencies of anti-host reactive cd8+ t cells ignore non-hematopoietic antigen after bone marrow transplantation in a murine model A Gassa, H Kalkavan, F Jian, V Duhan, V Khairnar, N Shaabani, N Honke, ... Cellular Physiology and Biochemistry 38 (4), 1343-1353, 2016 | 5 | 2016 |
Quantitative real‐time ARMS‐qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients A Hoerning, H Kalkavan, C Rehme, J Menke, K Worm, HSP Garritsen, ... Pediatric transplantation 15 (8), 809-818, 2011 | 5 | 2011 |
Viral infection overcomes ineffectiveness of anti-tumoral CD8+ T cell mediated cytotoxicity F Zhou, J Kardash, H Bhat, V Duhan, SK Friedrich, J Bezgovsek, ... bioRxiv, 591198, 2019 | 1 | 2019 |
Arenaviruses for use in the treatment and/or prevention of tumors and method for producing arenaviruses with (improved) tumor-regression properties. KS Lang, H Kalkavan US Patent App. 15/567,343, 2018 | 1 | 2018 |
Arenaviruses for use in the treatment and/or prevention of tumors and method for producing arenaviruses with (im-proved) tumor-regression properties KS Lang, H Kalkavan US Patent App. 18/385,250, 2024 | | 2024 |
PIGMENT CELL & MELANOMA Research M Lever, S Bogner, M Giousmas, FD Mairinger, HA Baba, H Richly, ... | | 2024 |
Metastasierte nicht-kleinzellige Lungenkarzinome – Aktuelles zur Therapie und Ausblick M Webendörfer, M Wiesweg, H Kalkavan, M Schuler JOURNAL ONKOLOGIE, 2024 | | 2024 |
Prognostic value of clinical and radiomicparameters in patients with liver metastasesfrom uveal melanoma M Lever, S Bogner, M Giousmas, FD Mairinger, HA Baba, H Richly, ... | | 2024 |